Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-01

Clinical Trial Update: Efficacy of Roflumilast in Prevention of Peripheral Neuropathy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update investigating the efficacy of roflumilast for prevention of peripheral neuropathy in early-phase studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Roflumilast (roflumilast)

Snippet

Sponsor: Mansoura University | Conditions: Peripheral Neuropathy | Phase 1, Phase 2 | Status: UNKNOWN